Open for inclusion

A phase 1 study to evaluate safety, feasibility and immunologic response of adoptive T cell transfer with or without dendritic cell vaccination in patients with metastatic melanoma

Cancer type: Melanoma

Phase: I

Principal Investigator: Tell Roger

Country: SE

Keywords: Sweden, 2012-000450-63, MAT02

Status: Open for inclusion

Link to Clinicaltrials.gov: http://www.clinicaltrials.gov/ct2/show/NCT01946373?term=NCT01946373&rank=1